Second malignancies after permanent implant prostate cancer brachytherapy: A single-institution study of 675  patients treated between 1999 and 2003.

CONCLUSION: With a mean follow-up of more than 11 years, this series does not detect any excess risk of second cancers associated with permanent implant prostate brachytherapy. However, due to power limitation, a small increase in the risk of secondary malignancies cannot be totally ruled out.
PMID: 28499661 [PubMed - as supplied by publisher]

Source: Cancer Radiotherapie - May 9, 2017 Category: Cancer & Oncology Authors: Cosset JM, Belin L, Wakil G, Flam T, Thiounn N, Pierrat N, Pontvert D, Savignoni A, Chauveinc L Tags: Cancer Radiother Source Type: research